CPMI and IOSCO published the third batch, consultative report on harmonization of critical OTC derivatives data elements (other than Unique Transaction Identifier, or UTI, and the Unique Product Identifier, or UPI). This report complements the consultative report on Harmonization of key OTC derivatives data elements (other than UTI and UPI)—first batch, on Harmonization of critical OTC derivatives data elements (other than UTI and UPI)—second batch, and on Harmonization of the Unique Transaction Identifier, along with the two consultative reports on harmonization of the UPI. CPMI and IOSCO issued the final technical guidance on UTI in February 2017 and plan to issue the one on UPI around mid-2017 and one on critical data elements in early 2018.
The report is a further step toward fulfilling the Group of 20's (G20) 2009 commitment to report all OTC derivatives contracts to, with the aim of improving transparency, mitigating systemic risk, and preventing market abuse. Aggregation of the data reported across trade repositories will help ensure that authorities can obtain a comprehensive view of trade repositories in the OTC derivatives market. The CPMI, IOSCO, and FSB have, in recent years, published reports to lay the foundation for the harmonization work on key OTC derivatives data elements for meaningful aggregation on a global basis, including the 2012 CPSS-IOSCO report on OTC derivatives data reporting and aggregation requirements, the 2013 CPSS-IOSCO report on Authorities' access to trade repository data, and the 2014 FSB Feasibility study on approaches to aggregate OTC derivatives data. Following the 2014 feasibility study, the FSB asked the CPMI and IOSCO to develop global guidance on the harmonization of data elements reported to trade repositories and important for the aggregation of data by authorities, including the UTI and the UPI. This consultative report is part of the Harmonization Group's response to that mandate.
Comments Due Date: August 30, 2017
Keywords: International, Trade Repository, OTC Derivatives, CPMI, IOSCO, Securities, UPI, UTI
BCBS is consulting on the principles for operational resilience and the revisions to the principles for sound management of operational risk for banks.
The Financial Stability Institute (FSI) of BIS published a brief note that examines the supervisory challenges associated with certain temporary regulatory relief measures introduced by BCBS and prudential authorities in response to the COVID-19 pandemic.
HKMA, together with the Banking Sector Small and Medium-Size Enterprise (SME) Lending Coordination Mechanism, announced a ninety-day repayment deferment for trade facilities under the Pre-approved Principal Payment Holiday Scheme.
The Advisory Scientific Committee of ESRB published a response, in the form of an Insights Paper, to the EBA proposals for reforms to the stress testing framework in EU.
MAS announced several initiatives to support adoption of the Singapore Overnight Rate Average (SORA), which is administered by MAS.
BoE updated the reporting template for Form ER as well as the Form ER definitions, which contain guidance on the methodology to be used in calculating annualized interest rates.
PRA published the policy statement PS19/20 on the final policy for extending coverage under the Financial Services Compensation Scheme (FSCS) for Temporary High Balance.
EBA published the final draft implementing technical standards for disclosures and reporting on the minimum requirements for own funds and eligible liabilities (MREL) and the total loss-absorbing capacity (TLAC) requirements in EU.
EBA published an erratum for the phase 2 of technical package on the reporting framework 2.10.
EC published the Implementing Regulation 2020/1145, which lays down technical information for calculation of technical provisions and basic own funds.